scholarly journals Previous hepatitis E virus infection, cirrhosis and insulin resistance in patients with chronic hepatitis C

2019 ◽  
Vol 23 (1) ◽  
pp. 45-52 ◽  
Author(s):  
Guilherme Bricks ◽  
Jorge Figueiredo Senise ◽  
Henrique Pott-Jr ◽  
Giuliano Grandi ◽  
Dimas Carnaúba-Jr ◽  
...  
2018 ◽  
Vol 22 (2) ◽  
pp. 85-91 ◽  
Author(s):  
Guilherme Bricks ◽  
Jorge Figueiredo Senise ◽  
Henrique Pott Junior ◽  
Giuliano Grandi ◽  
Amanda Passarini ◽  
...  

2004 ◽  
Vol 41 (1) ◽  
pp. 132-138 ◽  
Author(s):  
Ryoichi Narita ◽  
Shintaro Abe ◽  
Yasuyuki Kihara ◽  
Toshiharu Akiyama ◽  
Akinari Tabaru ◽  
...  

2021 ◽  
Author(s):  
Mariana Cavalheiro Magri ◽  
Caroline Manchiero ◽  
Bianca Peixoto Dantas ◽  
Arielle Karen da Silva Nunes ◽  
Gerusa Maria Figueiredo ◽  
...  

Aim: We investigated the prevalence of anti-hepatitis E virus (HEV) antibodies in patients with chronic hepatitis C and the relationship with liver injury stage. Materials & methods: In total, 451 patients were included and the presence of anti-HEV antibodies was evaluated by ELISA. Results: Anti-HEV IgG antibodies were detected in 45 (10.0%) patients and anti-HEV IgM were detected in two IgG-positive patients (4.4%). The distributions of liver fibrosis, steatosis, inflammatory activity, homeostasis model assessment of insulin resistance and liver enzyme levels were similar between HEV-positive and HEV-negative patients. However, HEV-positive patients had a higher mean age (p = 0.030). The seroprevalence by age group increased from 2.2 (18–30 years) to 53.3% (>60 years). HEV infection was not related to advanced fibrosis. Conclusion: This investigation showed that the seroprevalence of HEV among patients with chronic hepatitis C is similar to that of blood donors in the same region.


Sign in / Sign up

Export Citation Format

Share Document